Vault-13

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

London, X0 · CIK 942257 · 13F filing filed 2023-11-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

As an employer

In the UK

1 UK companies in the group; those with staff figures, a pay gap report, FCA authorisation or fund management as their business are listed.

Sources: Companies House (accounts filed electronically; the largest groups often file on paper, so their staff numbers can be missing), the UK gender pay gap service (employers with 250+ staff) and the FCA's Financial Services Register. Contains public sector information licensed under the Open Government Licence v3.0.

$296.8m reported value -9.6% vs Q2 2023
65positions
47.8%in top 10
9 new 18 added 13 reduced 5 sold out vs Q2 2023

Holdings, Q3 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AMGEN INC COM AMGN AMGN 79,246 $21.3m7.17% 7.17% ReducedShares held: Q4 2022 16.2k, Q1 2023 91.2k, Q2 2023 117.2k, Q3 2023 79.2k -38.0k -38,000 -32.4%
2 INCYTE CORP COM INCY INCY 358,454 $20.7m6.97% 6.97% UnchangedShares held: Q4 2022 229.0k, Q1 2023 279.0k, Q2 2023 358.5k, Q3 2023 358.5k
3 GILEAD SCIENCES INC COM GILD GILD 233,584 $17.5m5.90% 5.90% AddedShares held: Q4 2022 57.6k, Q1 2023 57.6k, Q2 2023 144.6k, Q3 2023 233.6k +89.0k +89,000 61.6%
4 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 317,856 $16.5m5.57% 5.57% AddedShares held: Q4 2022 221.9k, Q1 2023 257.9k, Q2 2023 176.9k, Q3 2023 317.9k +141.0k +141,000 79.7%
5 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 153,656 $13.6m4.58% 4.58% AddedShares held: Q4 2022 43.7k, Q1 2023 58.7k, Q2 2023 58.7k, Q3 2023 153.7k +95.0k +95,000 162.0%
6 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 426,500 $11.8m3.96% 3.96% ReducedShares held: Q4 2022 383.5k, Q1 2023 423.5k, Q2 2023 523.5k, Q3 2023 426.5k -97.0k -97,000 -18.5%
7 VERA THERAPEUTICS INC CL A VERA VERA 758,355 $10.4m3.50% 3.50% ReducedShares held: Q4 2022 281.3k, Q1 2023 1.0m, Q2 2023 975.2k, Q3 2023 758.4k -216.9k -216,872 -22.2%
8 BIOGEN INC COM BIIB BIIB 40,200 $10.3m3.48% 3.48% AddedShares held: Q4 2022 21.4k, Q1 2023 21.4k, Q2 2023 11.0k, Q3 2023 40.2k +29.2k +29,200 265.4%
9 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 314,500 $10.3m3.47% 3.47% ReducedShares held: Q4 2022 264.5k, Q1 2023 570.5k, Q2 2023 570.5k, Q3 2023 314.5k -256.0k -256,000 -44.9%
10 MIRATI THERAPEUTICS INC COM MRTX MRTX 216,000 $9.4m3.17% 3.17% ReducedShares held: Q4 2022 244.0k, Q1 2023 244.0k, Q2 2023 260.0k, Q3 2023 216.0k -44.0k -44,000 -16.9%
11 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 250,052 $8.9m3.00% 3.00% AddedShares held: Q4 2022 174.1k, Q1 2023 264.1k, Q2 2023 80.1k, Q3 2023 250.1k +170.0k +170,000 212.4%
12 UNIQURE NV SHS QURE QURE 1,241,500 $8.3m2.81% 2.81% AddedShares held: Q4 2022 631.5k, Q1 2023 478.5k, Q2 2023 15.5k, Q3 2023 1.2m +1.2m +1,226,000 7909.7%
13 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 1,040,530 $8.1m2.72% 2.72% AddedShares held: Q4 2022 573.5k, Q1 2023 573.5k, Q2 2023 573.5k, Q3 2023 1.0m +467.0k +467,000 81.4%
14 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 33,959 $7.7m2.58% 2.58% ReducedShares held: Q4 2022 15.0k, Q1 2023 28.5k, Q2 2023 52.8k, Q3 2023 34.0k -18.8k -18,800 -35.6%
15 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 21,000 $7.3m2.46% 2.46% UnchangedShares held: Q4 2022 0, Q1 2023 33.0k, Q2 2023 21.0k, Q3 2023 21.0k
16 REGENERON PHARMACEUTICALS COM REGN REGN 8,847 $7.3m2.45% 2.45% ReducedShares held: Q4 2022 11.2k, Q1 2023 11.2k, Q2 2023 27.0k, Q3 2023 8.8k -18.2k -18,153 -67.2%
17 ILLUMINA INC COM ILMN ILMN 50,500 $6.9m2.34% 2.34% UnchangedShares held: Q4 2022 46.5k, Q1 2023 26.5k, Q2 2023 50.5k, Q3 2023 50.5k
18 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 36,800 $6.5m2.20% 2.20% ReducedShares held: Q4 2022 38.0k, Q1 2023 46.6k, Q2 2023 81.6k, Q3 2023 36.8k -44.8k -44,800 -54.9%
19 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 295,000 $5.4m1.82% 1.82% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 25.0k, Q3 2023 295.0k +270.0k +270,000 1080.0%
20 KRYSTAL BIOTECH INC COM KRYS KRYS 46,092 $5.3m1.80% 1.80% AddedShares held: Q4 2022 45.0k, Q1 2023 61.0k, Q2 2023 45.9k, Q3 2023 46.1k +147 +147 0.3%
21 KARUNA THERAPEUTICS INC COM COM 30,500 $5.2m1.74% 1.74% AddedShares held: Q4 2022 0, Q1 2023 11.0k, Q2 2023 25.7k, Q3 2023 30.5k +4.8k +4,800 18.7%
22 AXSOME THERAPEUTICS INC COM AXSM AXSM 58,300 $4.1m1.37% 1.37% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 58.3k, Q3 2023 58.3k
23 ERASCA INC COM ERAS ERAS 1,926,000 $3.8m1.28% 1.28% AddedShares held: Q4 2022 0, Q1 2023 1.4m, Q2 2023 1.4m, Q3 2023 1.9m +500.0k +500,000 35.1%
24 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 179,702 $3.7m1.26% 1.26% AddedShares held: Q4 2022 100.0k, Q1 2023 216.0k, Q2 2023 151.0k, Q3 2023 179.7k +28.7k +28,702 19.0%
25 REVANCE THERAPEUTICS INC COM RVNC RVNC 288,726 $3.3m1.11% 1.11% UnchangedShares held: Q4 2022 120.0k, Q1 2023 183.0k, Q2 2023 288.7k, Q3 2023 288.7k
26 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 28,877 $3.2m1.09% 1.09% ReducedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 68.9k, Q3 2023 28.9k -40.0k -40,000 -58.1%
27 SAREPTA THERAPEUTICS INC COM SRPT SRPT 26,700 $3.2m1.09% 1.09% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 18.8k, Q3 2023 26.7k +7.9k +7,900 42.0%
28 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 156,000 $3.2m1.08% 1.08% UnchangedShares held: Q4 2022 63.0k, Q1 2023 63.0k, Q2 2023 156.0k, Q3 2023 156.0k
29 DENALI THERAPEUTICS INC COM DNLI DNLI 154,000 $3.2m1.07% 1.07% ReducedShares held: Q4 2022 38.0k, Q1 2023 86.6k, Q2 2023 188.0k, Q3 2023 154.0k -34.0k -34,000 -18.1%
30 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 46,500 $3.1m1.06% 1.06% NewShares held: Q4 2022 65.0k, Q1 2023 65.0k, Q2 2023 0, Q3 2023 46.5k
31 XENON PHARMACEUTICALS INC COM XENE XENE 91,500 $3.1m1.05% 1.05% AddedShares held: Q4 2022 25.5k, Q1 2023 25.5k, Q2 2023 25.5k, Q3 2023 91.5k +66.0k +66,000 258.8%
32 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 63,000 $2.9m0.96% 0.96% NewShares held: Q4 2022 34.2k, Q1 2023 34.2k, Q2 2023 0, Q3 2023 63.0k
33 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 18,300 $2.7m0.90% 0.90% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 18.3k, Q3 2023 18.3k
34 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 38,000 $2.6m0.86% 0.86% UnchangedShares held: Q4 2022 38.0k, Q1 2023 38.0k, Q2 2023 38.0k, Q3 2023 38.0k
35 HALOZYME THERAPEUTICS INC COM HALO HALO 62,200 $2.4m0.80% 0.80% ReducedShares held: Q4 2022 0, Q1 2023 45.5k, Q2 2023 95.5k, Q3 2023 62.2k -33.3k -33,300 -34.9%
36 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 290,000 $2.3m0.79% 0.79% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 90.0k, Q3 2023 290.0k +200.0k +200,000 222.2%
37 BEIGENE LTD SPONSORED ADR ONC ONC 12,700 $2.3m0.77% 0.77% AddedShares held: Q4 2022 15.7k, Q1 2023 22.7k, Q2 2023 8.7k, Q3 2023 12.7k +4.0k +4,000 46.0%
38 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 17,200 $2.2m0.75% 0.75% UnchangedShares held: Q4 2022 17.2k, Q1 2023 17.2k, Q2 2023 17.2k, Q3 2023 17.2k
39 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 67,500 $2.1m0.72% 0.72% UnchangedShares held: Q4 2022 67.5k, Q1 2023 67.5k, Q2 2023 67.5k, Q3 2023 67.5k
40 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 445,000 $2.0m0.68% 0.68% AddedShares held: Q4 2022 56.0k, Q1 2023 56.0k, Q2 2023 65.0k, Q3 2023 445.0k +380.0k +380,000 584.6%
41 IONIS PHARMACEUTICALS INC COM IONS IONS 43,000 $1.9m0.66% 0.66% UnchangedShares held: Q4 2022 0, Q1 2023 43.0k, Q2 2023 43.0k, Q3 2023 43.0k
42 ZAI LAB LTD ADR ZLAB ZLAB 78,958 $1.9m0.65% 0.65% UnchangedShares held: Q4 2022 79.0k, Q1 2023 79.0k, Q2 2023 79.0k, Q3 2023 79.0k
43 GENMAB A/S SPONSORED ADS GMAB GMAB 44,300 $1.6m0.53% 0.53% NewShares held: Q4 2022 0, Q1 2023 88.0k, Q2 2023 0, Q3 2023 44.3k
44 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 48,099 $1.3m0.45% 0.45% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 48.1k, Q3 2023 48.1k
45 COGENT BIOSCIENCES INC COM COGT COGT 135,000 $1.3m0.44% 0.44% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 135.0k
46 DYNE THERAPEUTICS INC COM DYN DYN 137,751 $1.2m0.41% 0.41% ReducedShares held: Q4 2022 641.1k, Q1 2023 433.8k, Q2 2023 300.8k, Q3 2023 137.8k -163.0k -163,000 -54.2%
47 NOVOCURE LTD ORD SHS NVCR NVCR 74,000 $1.2m0.40% 0.40% AddedShares held: Q4 2022 32.0k, Q1 2023 32.0k, Q2 2023 32.0k, Q3 2023 74.0k +42.0k +42,000 131.2%
48 AMICUS THERAPEUTICS INC COM FOLD FOLD 90,000 $1.1m0.37% 0.37% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 90.0k
49 CYTOKINETICS INC COM NEW CYTK CYTK 37,000 $1.1m0.37% 0.37% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 37.0k, Q3 2023 37.0k
50 GUARDANT HEALTH INC COM GH GH 36,500 $1.1m0.36% 0.36% UnchangedShares held: Q4 2022 74.5k, Q1 2023 74.5k, Q2 2023 36.5k, Q3 2023 36.5k
51 INSMED INC COM PAR $.01 INSM INSM 40,100 $1.0m0.34% 0.34% UnchangedShares held: Q4 2022 40.1k, Q1 2023 40.1k, Q2 2023 40.1k, Q3 2023 40.1k
52 BLUEPRINT MEDICINES CORP COM BPMC BPMC 20,000 $1.0m0.34% 0.34% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 20.0k
53 AKERO THERAPEUTICS INC COM AKRO AKRO 18,489 $935.2k0.32% 0.32% ReducedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 78.5k, Q3 2023 18.5k -60.0k -60,000 -76.4%
54 KEZAR LIFE SCIENCES INC COM COM 703,825 $830.5k0.28% 0.28% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 703.8k
55 INTELLIA THERAPEUTICS INC COM NTLA NTLA 24,000 $757.9k0.26% 0.26% UnchangedShares held: Q4 2022 24.0k, Q1 2023 24.0k, Q2 2023 24.0k, Q3 2023 24.0k
56 PROTHENA CORP PLC SHS PRTA PRTA 15,000 $722.9k0.24% 0.24% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 15.0k
57 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 24,000 $593.5k0.20% 0.20% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 24.0k, Q3 2023 24.0k
58 BEAM THERAPEUTICS INC COM BEAM BEAM 23,500 $564.7k0.19% 0.19% UnchangedShares held: Q4 2022 23.5k, Q1 2023 23.5k, Q2 2023 23.5k, Q3 2023 23.5k
59 VENTYX BIOSCIENCES INC COM VTYX VTYX 15,000 $520.6k0.18% 0.18% UnchangedShares held: Q4 2022 0, Q1 2023 15.0k, Q2 2023 15.0k, Q3 2023 15.0k
60 VIR BIOTECHNOLOGY INC COM VIR VIR 47,000 $439.9k0.15% 0.15% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 47.0k
61 I MAB SPONSORED ADS NBP NBP 310,499 $409.9k0.14% 0.14% UnchangedShares held: Q4 2022 310.5k, Q1 2023 310.5k, Q2 2023 310.5k, Q3 2023 310.5k
62 PTC THERAPEUTICS INC COM PTCT PTCT 17,000 $380.6k0.13% 0.13% UnchangedShares held: Q4 2022 144.0k, Q1 2023 93.0k, Q2 2023 17.0k, Q3 2023 17.0k
63 ARVINAS INC COM ARVN ARVN 17,000 $333.5k0.11% 0.11% UnchangedShares held: Q4 2022 17.0k, Q1 2023 17.0k, Q2 2023 17.0k, Q3 2023 17.0k
64 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 19,900 $331.9k0.11% 0.11% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 19.9k, Q3 2023 19.9k
65 RELMADA THERAPEUTICS INC COM RLMD RLMD 10,000 $30.0k0.01% 0.01% UnchangedShares held: Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 10.0k, Q3 2023 10.0k

Sold out since Q2 2023

SecurityTickerShares held beforeValue then
APELLIS PHARMACEUTICALS INC APLS APLS 129,700 $11.8m129.7k shares
HORIZON PHARMA PLC 67,000 $6.9m67.0k shares
TRAVERE THERAPEUTICS INC TVTX TVTX 441,019 $6.8m441.0k shares
SAGE THERAPEUTICS INC SAGE SAGE 20,000 $939.4k20.0k shares
HUTCHMED CHINA LTD HCM HCM 68,000 $816.0k68.0k shares